Health Trials

Pancreas Cancer, Duct Cell Adenocarcinoma

2

Review clinical trials related to Pancreas Cancer, Duct Cell Adenocarcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

This is a multicenter, open-label FIH, Phase 1a (dose escalation), Phase 1b (dose expansion) and Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment.

Participants needed: 150
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: MBrace TherapeuticsUpdated: Feb 17, 2026Locations: 7
Eligibility criteria

Provide written consent on an informed consent form (ICF), approved by an Instit... [+18]

Non-melanoma skin cancer considered completely cured; [+27]

Read more
Status: Not yet recruiting

A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

To explore safety and efficacy of neoantigen personalized mRNA vaccines AK154 monotherapy or in combination with AK104/AK112 and sequential mFOLFIRINOX regime in Resected PDAC

Participants needed: 60
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: AkesoUpdated: Apr 6, 2025Locations: 1
Eligibility criteria

Voluntarily signed the informed consent form and complied with protocols require... [+8]

The presence of other pathologic types [+18]

Read more